INTRODUCTION
============

The evolution of oncoplastic breast surgery, particularly reduction therapeutic mammoplasty (TM) procedures, has grown over the years due to the demand for more aesthetically acceptable results.^[@R1]--[@R9]^ Furthermore, patients with redundant breast skin envelopes have benefited from utilizing the lower breast pole de-epithelized skin \[dermal flap (DF)\] in providing additional coverage to protect the prosthesis in implant-based breast reconstruction with more predictable outcomes.^[@R10],[@R11]^ Notably, the tenets of the multidisciplinary thoracic oncoplastic approach are ostensibly established in the literature gaining more popularity driven by high level of patient satisfaction.^[@R12]--[@R14]^ Acknowledging the advantages of both techniques (TM and DF), the authors have principally combined them to achieve a novel hybrid approach for chest wall reconstruction postresection of primary chest wall tumors (CWTs). This would improve the functional and aesthetic results without jeopardizing the oncological outcome. This article describes the technique and the outcome which to the authors' best of knowledge would the first time to describe in this context.

MATERIALS AND METHODS
=====================

Prospectively collected data from 9 consecutive patients in the period between January 2012 and June 2018 were reviewed and assessed retrospectively. The indications included women with moderate or large breasts presenting with an anteriorly located primary CWT. They were managed through a thoracic oncoplastic multidisciplinary team approach to optimize their perioperative treatment plan.

The patients' demographics, comorbidities, tumor characteristics, and the radiological diagnostic work-up were documented. The operative details, postoperative outcomes, patient's satisfaction survey, and follow-up were recorded. The 2-team single-stage approach for surgical resection and reconstruction for CWT using TM and DF is demonstrated in Figures [1](#F1){ref-type="fig"}--[4](#F4){ref-type="fig"} (**see figure, Supplemental Digital Content 1**, which displays: (A) preoperative photograph for a 34-year-old patient \[body mass index (BMI): 40 and active smoker\] with breast cup size J and grade III ptosis. B, Intraoperative photograph demonstrating the anterior chest wall defect (300 cm^2^) post en-bloc resection of tumor and adjacent ribs exposing the intrathoracic viscera and diaphragm. Note the rigid skeletal reconstruction using methylmethacrylate mesh (MMM) in preparation to be secured to the edge of the defect. Of note, a superomedial NAC pedicle was designed with breast tissue of 700 g resected from each side. C, Intraoperative photograph demonstrating the insetting of the inferiorly based DF over the MMM and suture of its cephalic free border to the inferolateral edge of the pectoralis major muscle, thus providing complete coverage of the mesh. D, Intraoperative photograph postwound closure and applying Incision negative pressure wound therapy (iNPWT) (Prevena Dressing; Kinetic Concepts, Inc., San Antonio, Tex.) to promote healing in this high-risk wound due to risk factors (BMI 40 and active smoker). E, Postoperative photograph 24 months showing healing of scars with primary intention, complete survival of the NAC on both sides with satisfactory shape and symmetry of both breasts, **<http://links.lww.com/PRSGO/B342>**).

![A 47-year-old patient with a giant cell tumor in the anterior left chest wall. A, preoperative photo showing breasts, cup size C, with grade III ptosis. B, CT scan of the thorax revealing a giant cell tumor of the left fourth rib in midclavicular line.](gox-8-e2593-g001){#F1}

![Intraoperative photograph demonstrating the wise pattern TM approach with superior pedicle NAC and de-epithelization inferior breast pole skin to create an inferiorly based DF. Note the nonrigid skeletal reconstruction for the anterior chest wall defect (150 cm^2^) with PPM post en bloc resection of tumor and adjacent ribs.](gox-8-e2593-g002){#F2}

![Intraoperative photograph demonstrating the insetting of the inferiorly based DF over the PPM and suture of its cephalic free border to the inferolateral edge of the pectoralis major muscle thus providing complete coverage of the mesh. Note the superior pedicled NAC that will be transposed to its new position as part of the Wise pattern mastopexy.](gox-8-e2593-g003){#F3}

![Postoperative photograph 18 months after the second-stage right contralateral symmetrization mastopexy showing healing of scars with primary intention, complete survival of the NAC on both sides with good shape and symmetry of both breasts.](gox-8-e2593-g004){#F4}

([See Video \[online\]](#video1){ref-type="other"}, which displays the multidisciplinary two-team approach for en-bloc resection of a right anterior chest wall chondrosarcoma in a 29-year-old patient. Strattice ADM was used to restore the skeletal chest wall integrity, while soft tissue coverage was achieved using the wise pattern TM and DF with simultaneous contralateral symmetrization reduction mammoplasty.)

Video 1.Enbloc resection. Video 1 from "Therapeutic mammoplasty and Dermal flap; a Novel Hybrid approach for chest wall reconstruction"0_ytr7jnwnKaltura

RESULTS
=======

The patient and tumor characteristics, operative details, follow-up period, and outcomes are summarized in Table [1](#T1){ref-type="table"}. Their age ranged from 28 to 73 years (mean 44.1), whereas the BMI ranged from 27 to 41 kg/m^2^ (mean 32.7). Chondrosarcoma was the commonest pathology (7/9), whereas giant cell tumor was in (2/9) cases. A wise pattern approach TM was performed in all patients. The superomedial NAC pedicle was the commonest performed (6/9) followed by superior pedicle (2/9) and superolateral (1/9). Breast tissue was resected in 66.6% (6/9) of the patients at the primary surgery with a range of 56--1,200 g (mean 424), whereas 33% (3/9) required only mastopexy. Contralateral breast symmetrization was performed in (7/9) \[6 reductions and 1 mastopexy\] \[5/7 simultaneously and 2/7 subsequent second stage\]. The DF was inferiorly based on all patients except one which was superiorly based due to the location of the tumor caudal to the inframammary fold. The numbers of the ribs resected were between 2 and 4 (median 3) with resultant defect size ranged from 90 to 300cm^2^ (mean 138). Adequate clear surgical margins were achieved in all patients. The resultant defect was repaired using MMM in (5/9), acelluar dermal matrix (Strattice, Lifecell, Allergan, N.J.) in (2/9), and polyprolene mesh (PPM) in (2/9). iNPWT (Prevena dressing) was used in high-risk patients (3/9) due to morbid obesity, diabetes, and smoking. During the follow-up period of 12--72 months (median 31), there was no local recurrence or mortality experienced. One patient experienced a superficial T junction breakdown which was managed conservatively; no surgical site infection (SSI) was encountered. All patients experienced complete survival of NAC with excellent functional and aesthetic results and high satisfaction rates.

###### 

Patient and Tumor Characteristics, Operative Details, and Follow-up Period

  Patient   Age (years)   BMI   Comorbidities                                        Breast Cup Size and Degree of Ptosis   Histopathology and Tumor Site                                                                 NAC Pedicle and Dermal Flap Base                                 Resected Breast Tissue                                       Skeletal Defect Size (cm^2^)   Modality of Skeletal Reconstruction   Contralateral Symmetrization Reduction or Mastopexy    Follow-up (months)
  --------- ------------- ----- ---------------------------------------------------- -------------------------------------- --------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------ ------------------------------ ------------------------------------- ------------------------------------------------------ --------------------
  1         53            41    Crohn's Disease                                      J Grade III ptoisis                    Chondrosarcoma anterior chest wall left third rib mid-clavicular line                         Supero medial NAC pedicle and inferiorly based DF                1200 g                                                       100                            PPM                                   Yes, separate second stage reduction mammoplasty       72
  2         31            35    Ex-smoker Previous bilateral reduction mammoplasty   F Grade III ptosis                     Chondrosarcoma mid and lower Sternum + adjacent costochondral junction                        Bilateral Superior lateral NAC pedicle and inferiorly based DF   390 g                                                        115                            MMM                                   Yes, simultaneous reduction mammoplasty single stage   54
  3         28            27    None                                                 DD Grade III ptosis                    Giant cell tumor anterior chest wall right second rib mid-clavicular line                     Supero medial NAC pedicle and inferiorly based DF                No breast tissues resected Only skin reduction (mastopexy)   90                             Strattice (ADM)                       Yes, simultaneous mastopexy single stage               19
  4         47            32    None                                                 C Grade III ptosis                     Gaint cell tumor anterior right 4^th^ rib between mid-clavicular and anterior axillary line   Superior NAC pedicle and inferiorly based DF                     No breast tissues resected Only skin reduction (mastopexy)   150                            PPM                                   No (patient choice)                                    34
  5         31            29    None                                                 D Grade III ptosis                     Chondrosarcoma anterior chest wall right third between mid-clavicular and mid line            Supero medial NAC pedicle and inferiorly based DF                No breast tissues resected Only skin reduction (mastopexy)   120                            MMM                                   No, (patient choice)                                   48
  6         71            30    Hypertensive exsmoker                                D Grade III ptosis                     Chondrosarcoma anterior chest wall left third between mid-clavicular and mid line             Superior NAC pedicle and inferiorly based DF                     80 g                                                         120                            MMM                                   Yes, simultaneous reduction mammoplasty single stage   31
  7         73            30    Arrhythmia                                           E Grade III ptosis                     Chondrosarcoma anterior chest wall left costal margin                                         Supero medial NAC pedicle and superiorly based DF                120 g                                                        150                            Strattice (ADM)                       Yes, simultaneous reduction mammoplasty single stage   18
  8         29            31    None                                                 D Grade III ptosis                     Chondrosarcoma anterior chest wall 3^rd^ mid-clavicular line                                  Supero medial NAC pedicle and inferiorly based DF                56 g                                                         100                            MMM                                   Yes, simultaneous reduction mammoplasty single stage   20
  9         34            40    Diabetic smoker                                      J Grade III ptosis                     Chondrosarcoma                                                                                Supero medial NAC pedicle and inferiorly based DF                700 g                                                        300                            MMM                                   Yes, simultaneous Reduction mammoplasty                12

ADM, acellular dermal matrix; PPM, polyprolene mesh; TM, therapeutic mammoplasty.

DISCUSSION
==========

The patient-driven evolution of the oncoplastic reduction mammoplasty for the management of breast cancer has, respectively, become popularized over the past 2 decades due to the demand for better functional and aesthetic results.^[@R1]--[@R8]^ Furthermore, more recent studies have broadened the indications and introduced the concept of extreme oncoplasty technique for management of locally advanced breast cancer.^[@R9]^ Along these lines, the authors advocated similar approach to manage female patients with anterior chest wall chondrosarcoma and giant cell tumors. Notably, these patients have excellent disease-free and survival rates with surgery considered the cornerstone of their management.^[@R15]^ Nevertheless, chest wall resection and reconstruction using conventional methods could be debilitating with less favorable functional and aesthetic outcomes.^[@R16]^ The ideal patient would be one with a moderate or large breast who will benefit from reduction or mastopexy with a moderate anterior chest wall skeletal defect post tumor extipiration. In this study, the majority of the patients were young and active, preferring a less invasive approach with attention to the aesthetic results without compromising the oncological outcome. Similarly, previous studies demonstrated the concept for providing the opportunity to design incisions that provide muscle sparing approaches and more aesthetically acceptable results with improvement of patient's satisfaction and overall quality of life.^[@R14],[@R17],[@R18]^ We have previously demonstrated the value and importance of the multidisciplinary approach for chest wall resection and reconstruction to provide complete well-vascularized coverage to minimize the SSI.^[@R14],[@R19]^ A step ahead is to achieve this goal with muscle sparing approach avoiding functional deficit with better quality of life. DF has proven to be valuable in coverage of breast implants for breast reconstruction.^[@R10],[@R11]^ Hence, we combined DF with TM as a muscle sparing approach to provide coverage and protection of the prosthesis used for either rigid or nonrigid skeletal reconstruction. Acknowledging the well-established indications for iNPWT reported in the literature,^[@R20]^ we have extended its application in thoracic oncoplasty procedures, which has proved to be valuable in high-risk patients. Although the most significant finding in this series is that all patients' treatment was completed without any SSI or NAC necrosis, there are limitations to this study due to its retrospective nature, single-center experience with small sample size, and the relatively medium follow-up period. The proximate collaboration between thoracic and oncoplastic surgeons to achieve a satisfactory oncological outcome along with the best aesthetic results is imperative. Therefore, the authors believe that this multidisciplinary approach could be added to the repertoire of techniques described in the literature for chest wall resection and reconstruction. It is safe, less invasive with superior aesthetic and functional outcome, and better quality of life when compared to conventional approaches.
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